Neurological Diseases Suppliers & Manufacturers

Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...

Founded in 1985, we are a private, closely held company passionate about delivering science-driven innovation with platform capabilities. Our scientific achievements include the world’s first peptide-based diagnostic test and first fully synthetic ...

Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate ground-breaking science into medicines that ...

C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...

VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack ...

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a ...

At UNITY we are developing therapeutics to slow, halt, or reverse diseases of aging. Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial ...

After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...

DIERS International GmbH was founded in Wiesbaden in 1996. The company founder, Dipl. Eng. Helmut Diers, first completed an international career with various globally operating medical technology companies. From the beginning, close scientific ...

Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...

Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...

Drug Free Therapeutix (DFTx) provides intelligent software for medical device companies in or entering the lucrative $4BB pain management device market. Our platform technology, known as Extraneural Activation Control Technology (EXACT), fine-tunes ...

about-us-imageNDI (Neuro Device Innovations) is a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies. NDI pursues, funds and develops opportunities that address unmet clinical needs with ...

Marsi Bionics (Marsi) is an SME founded in 2013 as a spin-off from the Centro de Automática y Robótica (CAR), a joint centre of the Universidad Politécnica de Madrid (UPM) and the Spanish National Research Council (CSIC). Since 2019 the CSIC is part ...

A leading pioneer in leveraging iPSC innovation for drug discovery. The catalyst with the requisite iPSC know-how and experience to empower innovators in drug discovery to advance their science relentlessly, consistently and efficiently. For the ...

nVector enables and accelerates breakthrough treatments for previously untreatable diseases of the central nervous system. Iron Horse Diagnostics, Inc. is a privately held molecular diagnostic company focused on the development and commercialization ...

Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug ...

STORZ MEDICAL AG, founded in 1987, is an independent partner company of the KARL STORZ Group. We are a medical technology manufacturer located in the heart of Europe, on the Swiss shore of Lake Constance in Tägerwilen, and we develop innovative ...

Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing outstanding products and services for human protein biomarker discovery. Our groundbreaking Olink panels for precision proteomics help ...